Phenotypic Variability Correlates with Clinical Outcome in <italic toggle="yes">Cryptococcus</italic> Isolates Obtained from Botswanan HIV/AIDS Patients

ABSTRACT Pathogenic species of Cryptococcus cause hundreds of thousands of deaths annually. Considerable phenotypic variation is exhibited during infection, including increased capsule size, capsule shedding, giant cells (≥15 μm), and micro cells (≤1 μm). We examined 70 clinical isolates of Cryptoco...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kenya E. Fernandes, Adam Brockway, Miriam Haverkamp, Christina A. Cuomo, Floris van Ogtrop, John R. Perfect, Dee A. Carter
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/e1e48f1ce27247bdb21547fce1bf3298
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e1e48f1ce27247bdb21547fce1bf3298
record_format dspace
spelling oai:doaj.org-article:e1e48f1ce27247bdb21547fce1bf32982021-11-15T15:58:21ZPhenotypic Variability Correlates with Clinical Outcome in <italic toggle="yes">Cryptococcus</italic> Isolates Obtained from Botswanan HIV/AIDS Patients10.1128/mBio.02016-182150-7511https://doaj.org/article/e1e48f1ce27247bdb21547fce1bf32982018-11-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02016-18https://doaj.org/toc/2150-7511ABSTRACT Pathogenic species of Cryptococcus cause hundreds of thousands of deaths annually. Considerable phenotypic variation is exhibited during infection, including increased capsule size, capsule shedding, giant cells (≥15 μm), and micro cells (≤1 μm). We examined 70 clinical isolates of Cryptococcus neoformans and Cryptococcus tetragattii from HIV/AIDS patients in Botswana to determine whether the capacity to produce morphological variants was associated with clinical parameters. Isolates were cultured under conditions designed to simulate in vivo stresses. Substantial variation was seen across morphological and clinical data. Giant cells were more common in C. tetragattii, while micro cells and shed capsule occurred in C. neoformans only. Phenotypic variables fell into two groups associated with differing symptoms. The production of “large” phenotypes (greater cell and capsule size and giant cells) was associated with higher CD4 count and was negatively correlated with intracranial pressure indicators, suggesting that these are induced in early stage infection. “Small” phenotypes (micro cells and shed capsule) were associated with lower CD4 counts, negatively correlated with meningeal inflammation indicators, and positively correlated with intracranial pressure indicators, suggesting that they are produced later during infection and may contribute to immune suppression and promote proliferation and dissemination. These trends persisted at the species level, indicating that they were not driven by association with particular Cryptococcus species. Isolates possessing giant cells, micro cells, and shed capsule were rare, but strikingly, they were associated with patient death (P = 0.0165). Our data indicate that pleomorphism is an important driver in Cryptococcus infection. IMPORTANCE Cryptococcosis results in hundreds of thousands of deaths annually, predominantly in sub-Saharan Africa. Cryptococcus is an encapsulated yeast, and during infection, cells have the capacity for substantial morphological changes, including capsule enlargement and shedding and variations in cell shape and size. In this study, we examined 70 Cryptococcus isolates causing meningitis in HIV/AIDS patients in Botswana in order to look for associations between phenotypic variation and clinical symptoms. Four variant phenotypes were seen across strains: giant cells of ≥15 µm, micro cells of ≤1 µm, shed extracellular capsule, and irregularly shaped cells. We found that “large” and “small” phenotypes were associated with differing disease symptoms, indicating that their production may be important during the disease process. Overall, our study indicates that Cryptococcus strains that can switch on cell types under different situations may be more able to sustain infection and resist the host response.Kenya E. FernandesAdam BrockwayMiriam HaverkampChristina A. CuomoFloris van OgtropJohn R. PerfectDee A. CarterAmerican Society for MicrobiologyarticleCryptococcuscapsulecell sizemeningitispleomorphismyeastsMicrobiologyQR1-502ENmBio, Vol 9, Iss 5 (2018)
institution DOAJ
collection DOAJ
language EN
topic Cryptococcus
capsule
cell size
meningitis
pleomorphism
yeasts
Microbiology
QR1-502
spellingShingle Cryptococcus
capsule
cell size
meningitis
pleomorphism
yeasts
Microbiology
QR1-502
Kenya E. Fernandes
Adam Brockway
Miriam Haverkamp
Christina A. Cuomo
Floris van Ogtrop
John R. Perfect
Dee A. Carter
Phenotypic Variability Correlates with Clinical Outcome in <italic toggle="yes">Cryptococcus</italic> Isolates Obtained from Botswanan HIV/AIDS Patients
description ABSTRACT Pathogenic species of Cryptococcus cause hundreds of thousands of deaths annually. Considerable phenotypic variation is exhibited during infection, including increased capsule size, capsule shedding, giant cells (≥15 μm), and micro cells (≤1 μm). We examined 70 clinical isolates of Cryptococcus neoformans and Cryptococcus tetragattii from HIV/AIDS patients in Botswana to determine whether the capacity to produce morphological variants was associated with clinical parameters. Isolates were cultured under conditions designed to simulate in vivo stresses. Substantial variation was seen across morphological and clinical data. Giant cells were more common in C. tetragattii, while micro cells and shed capsule occurred in C. neoformans only. Phenotypic variables fell into two groups associated with differing symptoms. The production of “large” phenotypes (greater cell and capsule size and giant cells) was associated with higher CD4 count and was negatively correlated with intracranial pressure indicators, suggesting that these are induced in early stage infection. “Small” phenotypes (micro cells and shed capsule) were associated with lower CD4 counts, negatively correlated with meningeal inflammation indicators, and positively correlated with intracranial pressure indicators, suggesting that they are produced later during infection and may contribute to immune suppression and promote proliferation and dissemination. These trends persisted at the species level, indicating that they were not driven by association with particular Cryptococcus species. Isolates possessing giant cells, micro cells, and shed capsule were rare, but strikingly, they were associated with patient death (P = 0.0165). Our data indicate that pleomorphism is an important driver in Cryptococcus infection. IMPORTANCE Cryptococcosis results in hundreds of thousands of deaths annually, predominantly in sub-Saharan Africa. Cryptococcus is an encapsulated yeast, and during infection, cells have the capacity for substantial morphological changes, including capsule enlargement and shedding and variations in cell shape and size. In this study, we examined 70 Cryptococcus isolates causing meningitis in HIV/AIDS patients in Botswana in order to look for associations between phenotypic variation and clinical symptoms. Four variant phenotypes were seen across strains: giant cells of ≥15 µm, micro cells of ≤1 µm, shed extracellular capsule, and irregularly shaped cells. We found that “large” and “small” phenotypes were associated with differing disease symptoms, indicating that their production may be important during the disease process. Overall, our study indicates that Cryptococcus strains that can switch on cell types under different situations may be more able to sustain infection and resist the host response.
format article
author Kenya E. Fernandes
Adam Brockway
Miriam Haverkamp
Christina A. Cuomo
Floris van Ogtrop
John R. Perfect
Dee A. Carter
author_facet Kenya E. Fernandes
Adam Brockway
Miriam Haverkamp
Christina A. Cuomo
Floris van Ogtrop
John R. Perfect
Dee A. Carter
author_sort Kenya E. Fernandes
title Phenotypic Variability Correlates with Clinical Outcome in <italic toggle="yes">Cryptococcus</italic> Isolates Obtained from Botswanan HIV/AIDS Patients
title_short Phenotypic Variability Correlates with Clinical Outcome in <italic toggle="yes">Cryptococcus</italic> Isolates Obtained from Botswanan HIV/AIDS Patients
title_full Phenotypic Variability Correlates with Clinical Outcome in <italic toggle="yes">Cryptococcus</italic> Isolates Obtained from Botswanan HIV/AIDS Patients
title_fullStr Phenotypic Variability Correlates with Clinical Outcome in <italic toggle="yes">Cryptococcus</italic> Isolates Obtained from Botswanan HIV/AIDS Patients
title_full_unstemmed Phenotypic Variability Correlates with Clinical Outcome in <italic toggle="yes">Cryptococcus</italic> Isolates Obtained from Botswanan HIV/AIDS Patients
title_sort phenotypic variability correlates with clinical outcome in <italic toggle="yes">cryptococcus</italic> isolates obtained from botswanan hiv/aids patients
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/e1e48f1ce27247bdb21547fce1bf3298
work_keys_str_mv AT kenyaefernandes phenotypicvariabilitycorrelateswithclinicaloutcomeinitalictoggleyescryptococcusitalicisolatesobtainedfrombotswananhivaidspatients
AT adambrockway phenotypicvariabilitycorrelateswithclinicaloutcomeinitalictoggleyescryptococcusitalicisolatesobtainedfrombotswananhivaidspatients
AT miriamhaverkamp phenotypicvariabilitycorrelateswithclinicaloutcomeinitalictoggleyescryptococcusitalicisolatesobtainedfrombotswananhivaidspatients
AT christinaacuomo phenotypicvariabilitycorrelateswithclinicaloutcomeinitalictoggleyescryptococcusitalicisolatesobtainedfrombotswananhivaidspatients
AT florisvanogtrop phenotypicvariabilitycorrelateswithclinicaloutcomeinitalictoggleyescryptococcusitalicisolatesobtainedfrombotswananhivaidspatients
AT johnrperfect phenotypicvariabilitycorrelateswithclinicaloutcomeinitalictoggleyescryptococcusitalicisolatesobtainedfrombotswananhivaidspatients
AT deeacarter phenotypicvariabilitycorrelateswithclinicaloutcomeinitalictoggleyescryptococcusitalicisolatesobtainedfrombotswananhivaidspatients
_version_ 1718427060476575744